Need for Inclusion of High-Risk Populations and Standardisation of Immunogenicity Outcomes in Adult Pneumococcal Vaccine Trials.
The Lancet Infectious diseases(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined